Search research articles
Contact Us
Filters
Showing results (61-70 of 427) with videos related to
Page
of 43
Sort By:
Expert Opinion on Pharmacotherapy
|
July 4, 2014
Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy
Massimo Breccia, Matteo Molica, Irene Zacheo, et al.
Future Oncology (London, England)
|
February 12, 2025
Asciminib in the treatment of chronic myeloid leukemia in chronic phase
Alessandro Costa, Emilia Scalzulli, Maria Laura Bisegna, et al.
Cancers
|
October 13, 2021
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios
Francesca Palandri, Massimo Breccia, Valerio De Stefano, et al.
Frontiers in Oncology
|
April 2, 2021
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Fausto Castagnetti, Fabrizio Pane, Gianantonio Rosti, et al.
Expert Review of Hematology
|
February 8, 2021
Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Fabio Efficace, Marco Vignetti, Francesco Sparano, et al.
International Journal of Hematology
|
August 5, 2022
Asciminib as a third line option in chronic myeloid leukemia
Alessandro Laganà, Emilia Scalzulli, Ida Carmosino, et al.
Frontiers in Oncology
|
March 29, 2021
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, et al.
Current Cancer Drug Targets
|
June 15, 2022
Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New Agents
Massimo Breccia, Emilia Scalzulli, Sara Pepe, et al.
Best Practice & Research. Clinical Haematology
|
November 1, 2003
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia
Francesco Lo-Coco, Massimo Breccia, Nélida Noguera, et al.
Annals of Hematology
|
October 12, 2014
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment
Massimo Breccia, Matteo Molica, Irene Zacheo, et al.
Page
of 43
Search research articles
Search
Showing results (61-70 of 427) with videos related to
Sort By:
Page
of 43
Expert Opinion on Pharmacotherapy
|
July 4, 2014
Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy
Massimo Breccia, Matteo Molica, Irene Zacheo, et al.
Future Oncology (London, England)
|
February 12, 2025
Asciminib in the treatment of chronic myeloid leukemia in chronic phase
Alessandro Costa, Emilia Scalzulli, Maria Laura Bisegna, et al.
Cancers
|
October 13, 2021
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios
Francesca Palandri, Massimo Breccia, Valerio De Stefano, et al.
Frontiers in Oncology
|
April 2, 2021
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Fausto Castagnetti, Fabrizio Pane, Gianantonio Rosti, et al.
Expert Review of Hematology
|
February 8, 2021
Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Fabio Efficace, Marco Vignetti, Francesco Sparano, et al.
International Journal of Hematology
|
August 5, 2022
Asciminib as a third line option in chronic myeloid leukemia
Alessandro Laganà, Emilia Scalzulli, Ida Carmosino, et al.
Frontiers in Oncology
|
March 29, 2021
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, et al.
Current Cancer Drug Targets
|
June 15, 2022
Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New Agents
Massimo Breccia, Emilia Scalzulli, Sara Pepe, et al.
Best Practice & Research. Clinical Haematology
|
November 1, 2003
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia
Francesco Lo-Coco, Massimo Breccia, Nélida Noguera, et al.
Annals of Hematology
|
October 12, 2014
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment
Massimo Breccia, Matteo Molica, Irene Zacheo, et al.
Page
of 43